Anadys Pharmaceuticals, Inc. (ANDS) – Mergers and Acquisitions
-
Wedbush Downgrades Anadys Pharmaceuticals (ANDS) to Neutral; Announces Acquisition by Roche; Additional Takeover Targets Remain
-
Anadys Pharmaceuticals (ANDS) Acquired by Roche for $3.70/Share, 256% Premium
Back to ANDS Stock Lookup